These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16886597)

  • 1. Comparison of ID8 MOSE and VEGF-modified ID8 cell lines in an immunocompetent animal model for human ovarian cancer.
    Janát-Amsbury MM; Yockman JW; Anderson ML; Kieback DG; Kim SW
    Anticancer Res; 2006; 26(4B):2785-9. PubMed ID: 16886597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of local, non-viral IL12 gene therapy and systemic paclitaxel chemotherapy in a syngeneic ID8 mouse model for human ovarian cancer.
    Janát-Amsbury MM; Yockman JW; Anderson ML; Kieback DG; Kim SW
    Anticancer Res; 2006; 26(5A):3223-8. PubMed ID: 17094433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer.
    Greenaway J; Moorehead R; Shaw P; Petrik J
    Gynecol Oncol; 2008 Feb; 108(2):385-94. PubMed ID: 18036641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model.
    Hu L; Hofmann J; Holash J; Yancopoulos GD; Sood AK; Jaffe RB
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6966-71. PubMed ID: 16203789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocompetent orthotopic isograft mouse model of ovarian cancer for high-intensity focused ultrasound (HIFU) treatment.
    Chou ST; Rabkin BA; Dowling S; Vaezy S; Theiss P
    Comp Med; 2004 Dec; 54(6):645-51. PubMed ID: 15679262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of a nude mouse model bearing orthotopically transplanted human ovarian carcinoma expressing green fluorescent protein].
    Yin AL; Zhong M; Sun GQ; Wang LP; Zhao SS
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):484-6. PubMed ID: 18359721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.
    Connolly DC; Bao R; Nikitin AY; Stephens KC; Poole TW; Hua X; Harris SS; Vanderhyden BC; Hamilton TC
    Cancer Res; 2003 Mar; 63(6):1389-97. PubMed ID: 12649204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological characteristics of an established model of ovarian cancer in mice and its homologous cell lines].
    Zhang ZM; Zhang C; Zhang FH; Shan BE; Nakagawa S
    Ai Zheng; 2006 Jun; 25(6):701-7. PubMed ID: 16764764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].
    Ruan HY; Li DR; Li L; Guan X; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):482-6. PubMed ID: 17961340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of imageable model of T-cell lymphoma growing in syngenic mice.
    Vetvicka D; Hovorka O; Kovar L; Rihova B
    Anticancer Res; 2009 Nov; 29(11):4513-7. PubMed ID: 20032399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
    Yao DS; Li L; Garson K; Vanderhyden BC
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CSOC 882, a novel immortalized ovarian cancer cell line expressing EGFR, HER2, and activated AKT.
    Scoles DR; Pavelka J; Cass I; Tran H; Baldwin RL; Armstrong K; Karlan BY
    Gynecol Oncol; 2007 Jan; 104(1):120-8. PubMed ID: 16956650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y; Shen K; He CX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory effect of breast cancer metastasis suppressor l gene on metastasis of human ovarian cancer cell in vitro and in vivo].
    Jiang J; Xia M; Feng JB; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):398-402. PubMed ID: 17697602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of interleukin-12 transfection on proliferation of ovarian cancer SKOV3 cells in vitro and in vivo].
    Wang J; Zhang CQ; Liu J; Sui LH
    Ai Zheng; 2007 Dec; 26(12):1292-8. PubMed ID: 18076789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
    Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: functional similarity to the human disease and identification of prospective tumoral markers and targets.
    Urzúa U; Roby KF; Gangi LM; Cherry JM; Powell JI; Munroe DJ
    J Cell Physiol; 2006 Mar; 206(3):594-602. PubMed ID: 16245302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient inhibition of intraperitoneal human ovarian cancer growth and prolonged survival by gene transfer of vesicular stomatitis virus matrix protein in nude mice.
    Lin X; Chen X; Wei Y; Zhao J; Fan L; Wen Y; Wu H; Zhao X
    Gynecol Oncol; 2007 Mar; 104(3):540-6. PubMed ID: 17112567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants.
    Morera Y; Bequet-Romero M; Ayala M; Lamdán H; Agger EM; Andersen P; Gavilondo JV
    Angiogenesis; 2008; 11(4):381-93. PubMed ID: 19034678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer.
    Barber A; Zhang T; DeMars LR; Conejo-Garcia J; Roby KF; Sentman CL
    Cancer Res; 2007 May; 67(10):5003-8. PubMed ID: 17510432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.